[1]
“Chronic Kidney Disease in Type 2 Diabetes: A Narrative Review of SGLT2 Inhibitor Uptake and the Gap Between Guideline and Prescription”, JCDO, vol. 5, no. 1, pp. 31–36, Sep. 2025, doi: 10.5281/zenodo.22261282.